
Clinical Inspection Readiness Leader

職位描述
The Clinical Inspection Readiness Leader (CIRL) is an “expert” leader responsible to lead Clinical Inspection Readiness (IR) and Pre-Approval Inspection (PAI) activities and to identify strategic solutions for continued improvement across clinical, where needed.
The CIRL is expected to consistently lead in the process for gathering, analyzing and sharing of best practices and lessons learned. The CIRL may also participate in the design, implementation and maintenance of the Quality Risk Management processes and system within the Clinical perimeter, ensuring alignment with the evolution of the regulations and business needs. He/She can also be a Clinical Quality Risk/Alert Leader for assigned risks.
Overall, the CIRL leads large transversal projects that support inspection readiness for which significant changes/improvements to business processes are expected across R&D and beyond. He/she leads via a project management approach, through optimized processes, new technologies and innovation.
職位要求:
Experience required: Minimum of at least 12 years’ experience in the pharmaceutical industry, with at least 8-10 years’ experience in GCP clinical and/or GCP quality operations-related roles (e.g., GCP auditing, clinical trial monitoring, trial management or Pharmacovigilance) AND demonstrated ability to lead complex projects/assignments.
An extensive knowledge of Research & Development with past experience in clinical operations, preferably global clinical trial management and/or GCP quality assessment/assurance.
The following skills are also of particular importance:
Experience with CFDI, FDA, EMA or other regulatory inspections of sponsor, investigator sites, or CROs Quality focused with a high degree of personal accountability and commitment Demonstrated skills in self-motivation, taking initiative and working independently.
Strong project management skills (global clinical projects
clinical process improvement projects) including:
-Results driven with attention to detail and quality while overseeing and connecting with contributing stakeholders
-Excellent team leadership, presentation, interpersonal and communication skills (written and verbal)
-Rigor, diplomacy and good analytical abilities
-Strong facilitation skills: ability to lead effective cross-location and cross-functional meetings, through discussions on complex and potentially controversial topics.
-Demonstrated ability to bring consensus among diverse cross functional teams and to drive results within established timeline
-Demonstrated ability to anticipate problems/ changes impacts, consequences, and delays
work proactively and take the initiative for corrective measures.
-Ability to multi-task, handling a wide range of small, medium and long-term assignments in parallel and dealing with urgent issues as they arise with ability to prioritize assignments in accordance with assigned project deadlines.
Strong knowledge of international good clinical practices (ICH) and understanding of current regulatory requirements (FDA, EMEA) related/ applicable to the conduct of clinical trials, understanding of FDA Compliance Manual & EMA Compliance Manual.
Knowledge about requirements of New Drug Application (NDA)/ Market Authorization Application (MAA) submissions and e-submissions Strategy focused with ability to extrapolate detail without losing sight of big picture.
Ability to analyze trends and determine strategic improvement needs
ability to execute and monitor the implementation and progress of such improvement processes.
Competent in English (both written and verbal) to interact effectively in an international environment.
企業(yè)簡介
賽諾菲集團是一家全球領(lǐng)先的多元化醫(yī)藥健康企業(yè),專注于患者需求,傳播健康。全球100,000余名員工,業(yè)務(wù)遍及100個國家,新興市場實力均衡,表現(xiàn)強勁,位列第一,多元領(lǐng)域,覆蓋處方藥、健康藥業(yè)產(chǎn)品、疫苗和動物保健品,疫苗領(lǐng)域的領(lǐng)導(dǎo)者
領(lǐng)先動物保健市場,2011年集團凈銷售額達(dá)334億歐元
賽諾菲在中國
賽諾菲是首批在中國開設(shè)辦事處的跨國制藥集團,也是國內(nèi)增長最快的醫(yī)藥健康企業(yè)之一。目前,賽諾菲在中國200多個城市擁有6000余名員工。
傳承悠久歷史、持續(xù)開拓進(jìn)取
賽諾菲一直以來秉承對中國的承諾。1982年,賽諾菲成為首批在中國開設(shè)辦事處的跨國制藥企業(yè)之一。今天,賽諾菲已躋身中國醫(yī)藥健康市場的領(lǐng)軍企業(yè)。賽諾菲的中國總部位于上海,并在北京、天津、沈陽、濟南、上海、杭州、南京、武漢、成都、廣州和烏魯木齊共設(shè)11家區(qū)域辦公室。
獨特的醫(yī)藥健康產(chǎn)品系列、滿足中國公共衛(wèi)生需求
從預(yù)防到治療,賽諾菲全方位滿足中國的公共健康需求。集團的疫苗事業(yè)部賽諾菲巴斯德是中國領(lǐng)先的疫苗企業(yè)。賽諾菲在心血管/血栓、糖尿病、腫瘤、內(nèi)科和中樞神經(jīng)系統(tǒng)等關(guān)鍵的治療領(lǐng)域擁有領(lǐng)先產(chǎn)品。2010年,杭州賽諾菲民生健康藥業(yè)有限公司的成立標(biāo)志著賽諾菲進(jìn)入中國的非處方藥市場。2011年2月,賽諾菲完成了對BMP太陽石的收購。
大幅投資工業(yè)建設(shè)、滿足中國市場需求
賽諾菲目前在中國擁有六家生產(chǎn)基地,包括北京制藥工廠、杭州制藥工廠、杭州賽諾菲民生健康藥業(yè)工廠、南昌梅里亞動物保健工廠、深圳賽諾菲巴斯德疫苗工廠、以及唐山健康藥業(yè)工廠。
完善的研發(fā)架構(gòu)、雙贏的研發(fā)合作模式
在中國,賽諾菲具有從藥物靶點發(fā)現(xiàn)到后期臨床研究的整體研發(fā)實力。集團在上海設(shè)有中國研發(fā)中心和亞太研發(fā)中心,并在北京和成都分別設(shè)有研發(fā)機構(gòu)。自2008年以來,賽諾菲與中國權(quán)威科研機構(gòu)開展了10多項戰(zhàn)略合作,在癌癥、干細(xì)胞、糖尿病和老年疾病等前沿研究領(lǐng)域探索創(chuàng)新藥物
依托于強勁的研發(fā)能力和多領(lǐng)域領(lǐng)先水平的廣泛的醫(yī)藥產(chǎn)品資源,公司在中國的市場份額不斷攀升,公司規(guī)模不斷擴大,飛速發(fā)展的業(yè)務(wù)給了我們與更多優(yōu)秀人才合作的機會。
如需了解更多信息,請訪問www.sanofi.cn
現(xiàn)在就行動!把握機遇,加入我們,您的職業(yè)生涯將與賽諾菲共同成長!抓住機會,來親身體驗我們所秉持的膽略、創(chuàng)新、團結(jié)、勇氣的價值觀。
請將您的中英文簡歷發(fā)給我們,并在email標(biāo)題欄注明您所申請的職位名稱。每個職位申請一次即可,請不要重復(fù)投遞簡歷。謝謝!
職位發(fā)布企業(yè)

賽諾菲中國
企業(yè)性質(zhì):外資企業(yè)
企業(yè)規(guī)模:5000-10000人
成立年份:1994
企業(yè)網(wǎng)址:www.sanofi.cn
企業(yè)地址:上海市 靜安區(qū)延安中路1228號 靜安嘉里中心辦公樓3座19樓
該企業(yè)其他職位更多>>
相關(guān)職位推薦
北京相關(guān)職位: 工程師(醫(yī)療售后)
熱門區(qū)域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
北京招聘企業(yè): 寶日醫(yī)生物技術(shù)(北京)有限公司 叮當(dāng)智慧藥房(北京)有限公司 北京久峰潤達(dá)生物技術(shù)有限公司 北京協(xié)和醫(yī)院 北京海斯美醫(yī)藥技術(shù)有限公司 北京策知易咨詢有限公司 北京萬泰生物藥業(yè)有限公司 百濟神州 北京凱霖娜國際貿(mào)易有限公司好益生醫(yī)院分公司 中國生物制藥有限公司
職位發(fā)布日期: 2019-04-01